Periodic Paralysis Treatment Market 2027 By Type, Drugs, Distribution Channel, End User | The Insight Partners

Periodic Paralysis Treatment Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type (Hypokalemic Periodic Paralysis, Hyperkalemic Periodic Paralysis, Thyrotoxic Periodic Paralysis, Others); Drugs (Beta-Blockers, Carbonic Anhydrase Inhibitors, Others); Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retailers, Others); End User (Hospitals, Homecare, Specialty Clinics, Others)

Report Code: TIPRE00015285 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Periodic paralysis is a rare inherited neuromuscular disorder identified by occasional muscle weakness, stiffness, or paralysis. These seizures can last for a few seconds to a few days, depending on their type. When there is a defect in the electrical-chemical communications between nerve cells and skeletal muscles, skeletal muscles cannot react to nerve signals resulting in temporary weakness of paralytic attacks.

MARKET DYNAMICS

The shortage of physical activity and the adoption of an unhealthy lifestyle, joint ventures by pharmaceuticals companies for the advancement of treatment are the major factors propelling Periodic paralysis treatment demand. However, limited availability of treatment options due to the low prevalence of periodic paralysis and fewer approvals of drugs from the regulatory authorities hinder the market growth during the forecast years. Moreover, the rising healthcare expenditure, substantial financial support to the researchers for developing novel interventions are anticipated to provide an opportunity for market growth.

MARKET SCOPE

The "Periodic Paralysis Treatment Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Periodic paralysis treatment market with detailed market segmentation by type, drugs, distribution channel, and end user. The Periodic paralysis treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Periodic paralysis treatment market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The periodic paralysis treatment market is segmented on the basis of type, drugs, distribution channel, and end user. Based on type, the market is segmented as hypokalemic periodic paralysis, hyperkalemic periodic paralysis, thyrotoxic periodic paralysis, and others. Based on drugs, the market is segmented as beta-blockers, carbonic anhydrase inhibitors, and others. Based on distribution channel, the market is segmented as hospital pharmacy, online pharmacy, retailers, and others. Based on end user, the market is segmented as hospitals, homecare, specialty clinics, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Periodic paralysis treatment market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Periodic paralysis treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Periodic paralysis treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Periodic paralysis treatment market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the periodic paralysis treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Periodic paralysis treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for Periodic paralysis treatment in the global market. Below mentioned is the list of few companies engaged in the Periodic paralysis treatment market.

The report also includes the profiles of key players in periodic paralysis treatment market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Strongbridge Biopharma plc
  •   Sun Pharmaceutical Industries Ltd
  •   Mylan N.V.
  •   Zydus Cadila
  •   Alembic Pharmaceuticals Limited
  •   X-GEN Pharmaceuticals, Inc
  •   Teva Pharmaceutical Industries Ltd
  •   Heritage

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Periodic Paralysis Treatment Market - By Type
1.3.2 Periodic Paralysis Treatment Market - By Drugs
1.3.3 Periodic Paralysis Treatment Market - By Distribution Channel
1.3.4 Periodic Paralysis Treatment Market - By End User
1.3.5 Periodic Paralysis Treatment Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PERIODIC PARALYSIS TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PERIODIC PARALYSIS TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PERIODIC PARALYSIS TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. PERIODIC PARALYSIS TREATMENT - GLOBAL MARKET OVERVIEW
6.2. PERIODIC PARALYSIS TREATMENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. PERIODIC PARALYSIS TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. HYPOKALEMIC PERIODIC PARALYSIS
7.3.1. Overview
7.3.2. Hypokalemic Periodic Paralysis Market Forecast and Analysis
7.4. HYPERKALEMIC PERIODIC PARALYSIS
7.4.1. Overview
7.4.2. Hyperkalemic Periodic Paralysis Market Forecast and Analysis
7.5. THYROTOXIC PERIODIC PARALYSIS
7.5.1. Overview
7.5.2. Thyrotoxic Periodic Paralysis Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. PERIODIC PARALYSIS TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - DRUGS
8.1. OVERVIEW
8.2. DRUGS MARKET FORECASTS AND ANALYSIS
8.3. BETA-BLOCKERS
8.3.1. Overview
8.3.2. Beta-Blockers Market Forecast and Analysis
8.4. CARBONIC ANHYDRASE INHIBITORS
8.4.1. Overview
8.4.2. Carbonic Anhydrase Inhibitors Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. PERIODIC PARALYSIS TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACY
9.3.1. Overview
9.3.2. Hospital Pharmacy Market Forecast and Analysis
9.4. ONLINE PHARMACY
9.4.1. Overview
9.4.2. Online Pharmacy Market Forecast and Analysis
9.5. RETAILERS
9.5.1. Overview
9.5.2. Retailers Market Forecast and Analysis
9.6. OTHERS
9.6.1. Overview
9.6.2. Others Market Forecast and Analysis
10. PERIODIC PARALYSIS TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. HOSPITALS
10.3.1. Overview
10.3.2. Hospitals Market Forecast and Analysis
10.4. HOMECARE
10.4.1. Overview
10.4.2. Homecare Market Forecast and Analysis
10.5. SPECIALTY CLINICS
10.5.1. Overview
10.5.2. Specialty Clinics Market Forecast and Analysis
10.6. OTHERS
10.6.1. Overview
10.6.2. Others Market Forecast and Analysis
11. PERIODIC PARALYSIS TREATMENT MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Periodic Paralysis Treatment Market Overview
11.1.2 North America Periodic Paralysis Treatment Market Forecasts and Analysis
11.1.3 North America Periodic Paralysis Treatment Market Forecasts and Analysis - By Type
11.1.4 North America Periodic Paralysis Treatment Market Forecasts and Analysis - By Drugs
11.1.5 North America Periodic Paralysis Treatment Market Forecasts and Analysis - By Distribution Channel
11.1.6 North America Periodic Paralysis Treatment Market Forecasts and Analysis - By End User
11.1.7 North America Periodic Paralysis Treatment Market Forecasts and Analysis - By Countries
11.1.7.1 United States Periodic Paralysis Treatment Market
11.1.7.1.1 United States Periodic Paralysis Treatment Market by Type
11.1.7.1.2 United States Periodic Paralysis Treatment Market by Drugs
11.1.7.1.3 United States Periodic Paralysis Treatment Market by Distribution Channel
11.1.7.1.4 United States Periodic Paralysis Treatment Market by End User
11.1.7.2 Canada Periodic Paralysis Treatment Market
11.1.7.2.1 Canada Periodic Paralysis Treatment Market by Type
11.1.7.2.2 Canada Periodic Paralysis Treatment Market by Drugs
11.1.7.2.3 Canada Periodic Paralysis Treatment Market by Distribution Channel
11.1.7.2.4 Canada Periodic Paralysis Treatment Market by End User
11.1.7.3 Mexico Periodic Paralysis Treatment Market
11.1.7.3.1 Mexico Periodic Paralysis Treatment Market by Type
11.1.7.3.2 Mexico Periodic Paralysis Treatment Market by Drugs
11.1.7.3.3 Mexico Periodic Paralysis Treatment Market by Distribution Channel
11.1.7.3.4 Mexico Periodic Paralysis Treatment Market by End User
11.2. EUROPE
11.2.1 Europe Periodic Paralysis Treatment Market Overview
11.2.2 Europe Periodic Paralysis Treatment Market Forecasts and Analysis
11.2.3 Europe Periodic Paralysis Treatment Market Forecasts and Analysis - By Type
11.2.4 Europe Periodic Paralysis Treatment Market Forecasts and Analysis - By Drugs
11.2.5 Europe Periodic Paralysis Treatment Market Forecasts and Analysis - By Distribution Channel
11.2.6 Europe Periodic Paralysis Treatment Market Forecasts and Analysis - By End User
11.2.7 Europe Periodic Paralysis Treatment Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Periodic Paralysis Treatment Market
11.2.7.1.1 Germany Periodic Paralysis Treatment Market by Type
11.2.7.1.2 Germany Periodic Paralysis Treatment Market by Drugs
11.2.7.1.3 Germany Periodic Paralysis Treatment Market by Distribution Channel
11.2.7.1.4 Germany Periodic Paralysis Treatment Market by End User
11.2.7.2 France Periodic Paralysis Treatment Market
11.2.7.2.1 France Periodic Paralysis Treatment Market by Type
11.2.7.2.2 France Periodic Paralysis Treatment Market by Drugs
11.2.7.2.3 France Periodic Paralysis Treatment Market by Distribution Channel
11.2.7.2.4 France Periodic Paralysis Treatment Market by End User
11.2.7.3 Italy Periodic Paralysis Treatment Market
11.2.7.3.1 Italy Periodic Paralysis Treatment Market by Type
11.2.7.3.2 Italy Periodic Paralysis Treatment Market by Drugs
11.2.7.3.3 Italy Periodic Paralysis Treatment Market by Distribution Channel
11.2.7.3.4 Italy Periodic Paralysis Treatment Market by End User
11.2.7.4 Spain Periodic Paralysis Treatment Market
11.2.7.4.1 Spain Periodic Paralysis Treatment Market by Type
11.2.7.4.2 Spain Periodic Paralysis Treatment Market by Drugs
11.2.7.4.3 Spain Periodic Paralysis Treatment Market by Distribution Channel
11.2.7.4.4 Spain Periodic Paralysis Treatment Market by End User
11.2.7.5 United Kingdom Periodic Paralysis Treatment Market
11.2.7.5.1 United Kingdom Periodic Paralysis Treatment Market by Type
11.2.7.5.2 United Kingdom Periodic Paralysis Treatment Market by Drugs
11.2.7.5.3 United Kingdom Periodic Paralysis Treatment Market by Distribution Channel
11.2.7.5.4 United Kingdom Periodic Paralysis Treatment Market by End User
11.2.7.6 Rest of Europe Periodic Paralysis Treatment Market
11.2.7.6.1 Rest of Europe Periodic Paralysis Treatment Market by Type
11.2.7.6.2 Rest of Europe Periodic Paralysis Treatment Market by Drugs
11.2.7.6.3 Rest of Europe Periodic Paralysis Treatment Market by Distribution Channel
11.2.7.6.4 Rest of Europe Periodic Paralysis Treatment Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Periodic Paralysis Treatment Market Overview
11.3.2 Asia-Pacific Periodic Paralysis Treatment Market Forecasts and Analysis
11.3.3 Asia-Pacific Periodic Paralysis Treatment Market Forecasts and Analysis - By Type
11.3.4 Asia-Pacific Periodic Paralysis Treatment Market Forecasts and Analysis - By Drugs
11.3.5 Asia-Pacific Periodic Paralysis Treatment Market Forecasts and Analysis - By Distribution Channel
11.3.6 Asia-Pacific Periodic Paralysis Treatment Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Periodic Paralysis Treatment Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Periodic Paralysis Treatment Market
11.3.7.1.1 Australia Periodic Paralysis Treatment Market by Type
11.3.7.1.2 Australia Periodic Paralysis Treatment Market by Drugs
11.3.7.1.3 Australia Periodic Paralysis Treatment Market by Distribution Channel
11.3.7.1.4 Australia Periodic Paralysis Treatment Market by End User
11.3.7.2 China Periodic Paralysis Treatment Market
11.3.7.2.1 China Periodic Paralysis Treatment Market by Type
11.3.7.2.2 China Periodic Paralysis Treatment Market by Drugs
11.3.7.2.3 China Periodic Paralysis Treatment Market by Distribution Channel
11.3.7.2.4 China Periodic Paralysis Treatment Market by End User
11.3.7.3 India Periodic Paralysis Treatment Market
11.3.7.3.1 India Periodic Paralysis Treatment Market by Type
11.3.7.3.2 India Periodic Paralysis Treatment Market by Drugs
11.3.7.3.3 India Periodic Paralysis Treatment Market by Distribution Channel
11.3.7.3.4 India Periodic Paralysis Treatment Market by End User
11.3.7.4 Japan Periodic Paralysis Treatment Market
11.3.7.4.1 Japan Periodic Paralysis Treatment Market by Type
11.3.7.4.2 Japan Periodic Paralysis Treatment Market by Drugs
11.3.7.4.3 Japan Periodic Paralysis Treatment Market by Distribution Channel
11.3.7.4.4 Japan Periodic Paralysis Treatment Market by End User
11.3.7.5 South Korea Periodic Paralysis Treatment Market
11.3.7.5.1 South Korea Periodic Paralysis Treatment Market by Type
11.3.7.5.2 South Korea Periodic Paralysis Treatment Market by Drugs
11.3.7.5.3 South Korea Periodic Paralysis Treatment Market by Distribution Channel
11.3.7.5.4 South Korea Periodic Paralysis Treatment Market by End User
11.3.7.6 Rest of Asia-Pacific Periodic Paralysis Treatment Market
11.3.7.6.1 Rest of Asia-Pacific Periodic Paralysis Treatment Market by Type
11.3.7.6.2 Rest of Asia-Pacific Periodic Paralysis Treatment Market by Drugs
11.3.7.6.3 Rest of Asia-Pacific Periodic Paralysis Treatment Market by Distribution Channel
11.3.7.6.4 Rest of Asia-Pacific Periodic Paralysis Treatment Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Periodic Paralysis Treatment Market Overview
11.4.2 Middle East and Africa Periodic Paralysis Treatment Market Forecasts and Analysis
11.4.3 Middle East and Africa Periodic Paralysis Treatment Market Forecasts and Analysis - By Type
11.4.4 Middle East and Africa Periodic Paralysis Treatment Market Forecasts and Analysis - By Drugs
11.4.5 Middle East and Africa Periodic Paralysis Treatment Market Forecasts and Analysis - By Distribution Channel
11.4.6 Middle East and Africa Periodic Paralysis Treatment Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Periodic Paralysis Treatment Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Periodic Paralysis Treatment Market
11.4.7.1.1 South Africa Periodic Paralysis Treatment Market by Type
11.4.7.1.2 South Africa Periodic Paralysis Treatment Market by Drugs
11.4.7.1.3 South Africa Periodic Paralysis Treatment Market by Distribution Channel
11.4.7.1.4 South Africa Periodic Paralysis Treatment Market by End User
11.4.7.2 Saudi Arabia Periodic Paralysis Treatment Market
11.4.7.2.1 Saudi Arabia Periodic Paralysis Treatment Market by Type
11.4.7.2.2 Saudi Arabia Periodic Paralysis Treatment Market by Drugs
11.4.7.2.3 Saudi Arabia Periodic Paralysis Treatment Market by Distribution Channel
11.4.7.2.4 Saudi Arabia Periodic Paralysis Treatment Market by End User
11.4.7.3 U.A.E Periodic Paralysis Treatment Market
11.4.7.3.1 U.A.E Periodic Paralysis Treatment Market by Type
11.4.7.3.2 U.A.E Periodic Paralysis Treatment Market by Drugs
11.4.7.3.3 U.A.E Periodic Paralysis Treatment Market by Distribution Channel
11.4.7.3.4 U.A.E Periodic Paralysis Treatment Market by End User
11.4.7.4 Rest of Middle East and Africa Periodic Paralysis Treatment Market
11.4.7.4.1 Rest of Middle East and Africa Periodic Paralysis Treatment Market by Type
11.4.7.4.2 Rest of Middle East and Africa Periodic Paralysis Treatment Market by Drugs
11.4.7.4.3 Rest of Middle East and Africa Periodic Paralysis Treatment Market by Distribution Channel
11.4.7.4.4 Rest of Middle East and Africa Periodic Paralysis Treatment Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Periodic Paralysis Treatment Market Overview
11.5.2 South and Central America Periodic Paralysis Treatment Market Forecasts and Analysis
11.5.3 South and Central America Periodic Paralysis Treatment Market Forecasts and Analysis - By Type
11.5.4 South and Central America Periodic Paralysis Treatment Market Forecasts and Analysis - By Drugs
11.5.5 South and Central America Periodic Paralysis Treatment Market Forecasts and Analysis - By Distribution Channel
11.5.6 South and Central America Periodic Paralysis Treatment Market Forecasts and Analysis - By End User
11.5.7 South and Central America Periodic Paralysis Treatment Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Periodic Paralysis Treatment Market
11.5.7.1.1 Brazil Periodic Paralysis Treatment Market by Type
11.5.7.1.2 Brazil Periodic Paralysis Treatment Market by Drugs
11.5.7.1.3 Brazil Periodic Paralysis Treatment Market by Distribution Channel
11.5.7.1.4 Brazil Periodic Paralysis Treatment Market by End User
11.5.7.2 Argentina Periodic Paralysis Treatment Market
11.5.7.2.1 Argentina Periodic Paralysis Treatment Market by Type
11.5.7.2.2 Argentina Periodic Paralysis Treatment Market by Drugs
11.5.7.2.3 Argentina Periodic Paralysis Treatment Market by Distribution Channel
11.5.7.2.4 Argentina Periodic Paralysis Treatment Market by End User
11.5.7.3 Rest of South and Central America Periodic Paralysis Treatment Market
11.5.7.3.1 Rest of South and Central America Periodic Paralysis Treatment Market by Type
11.5.7.3.2 Rest of South and Central America Periodic Paralysis Treatment Market by Drugs
11.5.7.3.3 Rest of South and Central America Periodic Paralysis Treatment Market by Distribution Channel
11.5.7.3.4 Rest of South and Central America Periodic Paralysis Treatment Market by End User
12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PERIODIC PARALYSIS TREATMENT MARKET
12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Rest of the World
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. PERIODIC PARALYSIS TREATMENT MARKET, KEY COMPANY PROFILES
14.1. STRONGBRIDGE BIOPHARMA PLC
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. SUN PHARMACEUTICAL INDUSTRIES LTD
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. MYLAN N.V.
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. ZYDUS CADILA
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. ALEMBIC PHARMACEUTICALS LIMITED
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. TEVA PHARMACEUTICAL INDUSTRIES LTD
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. X-GEN PHARMACEUTICALS, INC.
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. HERITAGE
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
The List of Companies

1. Strongbridge Biopharma plc
2. Sun Pharmaceutical Industries Ltd
3. Mylan N.V.
4. Zydus Cadila
5. Alembic Pharmaceuticals Limited
6. X-GEN Pharmaceuticals, Inc
7. Teva Pharmaceutical Industries Ltd
8. Heritage
TIPRE00015285
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking